LEAP TA: Life Sciences is the only event entirely dedicated to transforming how biotech and pharma organizations are ...

The 9th MASH Drug Development Summit is the essential forum for pharmaceutical giants and innovative biotechs dedicated to ...

After more than a decade of digital transformation, pharmaceutical marketing is on the cusp of achieving what the industry ...

With ongoing clinical trials and promising early data, tegoprubart may soon redefine the standard of care in transplantation ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

The team, led by Dr Phillip Jenkins, a postdoctoral fellow in clinical informatics at Oregon Health & Science University, ...

In the EV-303/KEYNOTE-905 study, the combination of nectin-4-directed antibody-drug conjugate (ADC) Padcev (enfortumab ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis (NFCB).

PureTech Health has launched a subsidiary company – Celea Therapeutics – with the task of taking an experimental drug for ...

Three key lessons the past five years of challenges and experience have taught us that we can use to move the biosimilars market forward.

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Citeline provides intelligence, data, and ...